Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
A Study of Post COVID-19 Mechanisms for Chronic Lung Sequelae
NCT06006884 · View on ClinicalTrials.gov ↗
Study Summary
The purpose of this study is to understand why some people experience long term effects, such as shortness of breath and fatigue, after a severe COVID-19 infection
Conditions Studied
Interventions
- PROCEDURE Bronchoscopies and Bronchoalveolar Lavages (BALs)
- DIAGNOSTIC_TEST Chest Tomography (CT)
- DIAGNOSTIC_TEST Electrocardiogram (ECG)
- DIAGNOSTIC_TEST Pulmonary function tests (PFTs)
- DIAGNOSTIC_TEST 6 minute walk test (6MWT)
Study Locations (1)
Minnesota
- Mayo Clinic Minnesota — Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2024-01-10 |
| Est. Completion | 2027-08 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06006884
The ClinicalTrials.gov registry entry for NCT06006884 describes a study currently listed as recruiting. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 3,246 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 5 interventions — of which Bronchoscopies and Bronchoalveolar Lavages (BALs) is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT06006884 reports 1 study location spanning 1 distinct geographic area — top geographies include Minnesota. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT06006884 about?
NCT06006884 is a clinical study titled "A Study of Post COVID-19 Mechanisms for Chronic Lung Sequelae". The purpose of this study is to understand why some people experience long term effects, such as shortness of breath and fatigue, after a severe COVID-19 infection
What is the current status of trial NCT06006884?
This trial is currently recruiting. The enrollment target is 75 participants. The study started on 2024-01-10. Estimated completion is 2027-08.
What conditions does trial NCT06006884 study?
This clinical trial studies the following conditions: COVID-19. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT06006884?
The interventions under investigation include: Bronchoscopies and Bronchoalveolar Lavages (BALs) (PROCEDURE), Chest Tomography (CT) (DIAGNOSTIC_TEST), Electrocardiogram (ECG) (DIAGNOSTIC_TEST), Pulmonary function tests (PFTs) (DIAGNOSTIC_TEST), 6 minute walk test (6MWT) (DIAGNOSTIC_TEST). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT06006884?
This trial is sponsored by Mayo Clinic, which has 3,246 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT06006884 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.